BackCME Group Overview
CME Group Inc - Ordinary Shares - Class A

CME Group Target Price

Analysts' average 12-month price target for CME Group is $310.

Get informed when a big investor buys or sells

+ Follow

Share Price

$281.29

Average Target Price

$306.388.9% upside

8 analysts in the last 4 months

High: $330 | Low: $260

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-19Deutsche Bank$2704% downsideOpen
2026-07-23Morgan StanleyMichael Cyprys$33017.3% upsideOpen
2026-07-15Piper Sandler$2954.9% upsideOpen
2026-07-10Morgan Stanley$32415.2% upsideOpen
2026-07-06UBSAlex Kramm$2607.6% downsideOpen
2026-06-17Piper SandlerPatrick Moley$32013.8% upsideOpen
2026-06-15Piper SandlerPatrick Moley$32917% upsideOpen
2026-06-11Redburn Partners$32314.8% upsideOpen
2026-04-23Morgan StanleyMichael Cyprys$35325.5% upsideOpen
2026-04-23Barclays$31612.3% upsideOpen
2026-04-10Morgan Stanley$36228.7% upsideOpen
2026-02-06UBS$31010.2% upsideOpen
2026-02-05RBC CapitalAshish Sabadra$3027.4% upsideOpen
2026-02-05Morgan Stanley$34020.9% upsideOpen
2026-02-05BarclaysBenjamin Budish$31210.9% upsideOpen
2026-01-15Morgan Stanley$31913.4% upsideOpen
2025-12-22Morgan StanleyMichael Cyprys$32013.8% upsideOpen
2025-12-12Barclays$3048.1% upsideOpen
2025-10-23Morgan StanleyMichael Cyprys$31411.6% upsideOpen
2025-10-23UBSAlex Kramm$2800.5% downsideOpen
2025-10-23Deutsche Bank$3006.7% upsideOpen
2025-10-13Raymond JamesPatrick O'Shaughnessy$3079.1% upsideOpen
2025-10-08Barclays$2800.5% downsideOpen
2025-10-01Morgan Stanley$31210.9% upsideOpen
2025-09-08UBSAlex Kramm$2851.3% upsideOpen
2025-07-24BarclaysBenjamin Budish$2985.9% upsideOpen
2025-03-10Raymond JamesPatrick O'Shaughnessy$2872% upsideOpen
2024-10-24OppenheimerOwen Lau$2588.3% downsideOpen
2024-10-24BarclaysBenjamin Budish$23117.9% downsideOpen
2024-10-03CitigroupChristopher Allen$25011.1% downsideOpen
2024-09-26RBC CapitalAshish Sabadra$23516.5% downsideOpen
2024-09-03Bank of America SecuritiesCraig Siegenthaler$17737.1% downsideOpen
2024-07-25Deutsche BankBrian Bedell$19331.4% downsideOpen
2024-07-25Piper SandlerPatrick Moley$22520% downsideOpen
2024-07-25BarclaysBenjamin Budish$20925.7% downsideOpen
2024-06-05UBSAlex Kromm$25011.1% downsideOpen
2024-04-25Rosenblatt SecuritiesAndrew Bond$18733.5% downsideOpen
2024-04-25BarclaysBenjamin Budish$22818.9% downsideOpen
2024-04-05Deutsche BankBrian Bedell$21025.3% downsideOpen
2023-02-07Credit Suisse$19829.6% downsideOpen
2023-01-11Morgan Stanley$19630.3% downsideOpen
2022-12-19Piper Sandler$25011.1% downsideOpen
2022-09-06Credit Suisse$21025.3% downsideOpen
2022-08-17Rosenblatt Securities$17139.2% downsideOpen
2022-08-12Deutsche Bank$21224.6% downsideOpen
2022-08-03Credit Suisse$21623.2% downsideOpen
2022-08-02UBS$24014.7% downsideOpen
2022-07-28Morgan Stanley$22619.7% downsideOpen
2022-07-28Credit Suisse$21822.5% downsideOpen
2022-07-19Morgan Stanley$24214% downsideOpen

CME Group (CME) FAQ

As of the most recent data, CME shows a target price of $310. Scroll down for historical charts and peer comparison views.

If CME Group moved to the average analyst target of $310, shares would be roughly 8.9% higher than $281.29. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of CME Group's earnings trajectory.

Besides this target price page, Stockcircle has CME Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $310) with ownership activity and broader fundamentals.

CME Group's target price is $310; compare it with other Finance names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.